Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-17

Clinical Trial Update: Naltrexone in the Treatment of Trichotillomania [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating naltrexone for treating trichotillomania has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of Chicago | Conditions: Trichotillomania | Phase 2 | Status: COMPLETED | Results posted: 2014-03-17